Karl Weddige, Ph.D. is an experienced Medical Science Liaison with a background in psychology and neuroscience. Karl has worked in various pharmaceutical companies such as Ironshore, IQVIA, Syneos Health, Sunovion Pharmaceuticals, and AstraZeneca, focusing on areas such as Attention-Deficit/Hyperactivity Disorder (ADHD), Parkinson’s Disease, Schizophrenia, Bipolar Disorder, and Major Depressive Disorder. Karl has also undertaken roles in research and management in the healthcare field.
April 1, 2024 - present
March, 2023
February, 2020